Literature DB >> 11709394

Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase.

I V Turko1, S Marcondes, F Murad.   

Abstract

High levels of reactive species of nitrogen and oxygen in diabetes may cause modifications of proteins. Recently, an increase in protein tyrosine nitration was found in several diabetic tissues. To understand whether protein tyrosine nitration is the cause or the result of the associated diabetic complications, it is essential to identify specific proteins vulnerable to nitration with in vivo models of diabetes. In the present study, we have demonstrated that succinyl-CoA:3-oxoacid CoA-transferase (SCOT; EC 2.8.3.5) is susceptible to tyrosine nitration in hearts from streptozotocin-treated rats. After 4 and 8 wk of streptozotocin administration and diabetes progression, SCOT from rat hearts had a 24% and 39% decrease in catalytic activity, respectively. The decrease in SCOT catalytic activity is accompanied by an accumulation of nitrotyrosine in SCOT protein. SCOT is a mitochondrial matrix protein responsible for ketone body utilization. Ketone bodies provide an alternative source of energy during periods of glucose deficiency. Because diabetes results in profound derangements in myocardial substrate utilization, we suggest that SCOT tyrosine nitration is a contributing factor to this impairment in the diabetic heart.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709394     DOI: 10.1152/ajpheart.2001.281.6.H2289

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  52 in total

Review 1.  The nitric oxide pathway in the cardiovascular system.

Authors:  S Llorens; J Jordán; E Nava
Journal:  J Physiol Biochem       Date:  2002-09       Impact factor: 4.158

2.  Oxidative stress status and placental implications in diabetic rats undergoing swimming exercise after embryonic implantation.

Authors:  Gustavo Tadeu Volpato; Débora Cristina Damasceno; Yuri Karen Sinzato; Viviane Maria Ribeiro; Marilza Vieira Cunha Rudge; Iracema Mattos Paranhos Calderon
Journal:  Reprod Sci       Date:  2014-10-30       Impact factor: 3.060

3.  Relative quantitation of protein nitration by liquid chromatography-mass spectrometry using isotope-coded dimethyl labeling and chemoprecipitation.

Authors:  Jia Guo; Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  J Chromatogr A       Date:  2012-01-09       Impact factor: 4.759

4.  The role of oxidative stress and antioxidants in diabetic complications.

Authors:  Fatmah A Matough; Siti B Budin; Zariyantey A Hamid; Nasar Alwahaibi; Jamaludin Mohamed
Journal:  Sultan Qaboos Univ Med J       Date:  2012-02-07

5.  Adaptation of myocardial substrate metabolism to a ketogenic nutrient environment.

Authors:  Anna E Wentz; D André d'Avignon; Mary L Weber; David G Cotter; Jason M Doherty; Robnet Kerns; Rakesh Nagarajan; Naveen Reddy; Nandakumar Sambandam; Peter A Crawford
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

Review 6.  Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.

Authors:  Pál Pacher; Irina G Obrosova; Jon G Mabley; Csaba Szabó
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 7.  Protein nitration in placenta - functional significance.

Authors:  R P Webster; V H J Roberts; L Myatt
Journal:  Placenta       Date:  2008-10-11       Impact factor: 3.481

Review 8.  Oxidative stress in the placenta.

Authors:  Leslie Myatt; Xiaolan Cui
Journal:  Histochem Cell Biol       Date:  2004-07-10       Impact factor: 4.304

Review 9.  Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.

Authors:  Zoltán V Varga; Zoltán Giricz; Lucas Liaudet; György Haskó; Peter Ferdinandy; Pál Pacher
Journal:  Biochim Biophys Acta       Date:  2014-07-02

Review 10.  Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.

Authors:  Claudia Figueroa-Romero; Mahdieh Sadidi; Eva L Feldman
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.